EFFICACY OF SIDDHALEPA SUPIRIVICKY TOOTHPASTE PROVEN IN REDUCING GINGIVITIS
Clinical research conducted in collaboration with the University of Würzburg, Germany, has proven the efficacy of Siddhalepa Supirivicky toothpaste in reducing clinical signs of gingival inflammation. Published in the International Journal of Dental Hygiene in 2024, the findings highlight the role of Siddhalepa Supirivicky in supporting gum health and mark an important milestone in the scientific research behind Sri Lanka’s first herbal toothpaste.
Gingivitis, an early stage of gum disease, is caused by plaque build-up along the gumline and can cause bleeding during brushing, redness, swelling and tenderness. The clinical study investigated the effects of Siddhalepa Supirivicky on clinical signs of gingivitis, finding that regular brushing was accompanied by a reduction in measures of gum inflammation. These findings support the toothpaste’s role in helping manage gingivitis as part of daily oral care.
Early intervention through appropriate oral hygiene and professional dental care is important, as untreated gingivitis can progress to more advanced gum disease, potentially damaging the tissues and bone supporting the teeth.
Founded in 1402, the University of Würzburg is one of the oldest universities in the world, with a history spanning more than six centuries of research and scientific discovery. Its Nobel Prize legacy includes 14 laureates who studied or taught at the university, reflecting its longstanding contribution to scientific advancement.
A 2025 study reported by the American Academy of Neurology found that older adults with gum disease were 56% more likely to have extensive white matter damage in the brain. Other research has indicated that periodontal disease can have a negative impact on diabetes, cardiovascular health and pregnancy,
Siddhalepa Supirivicky toothpaste is formulated using indigenous Ayurvedic ingredients, including Garcinia (Goraka), Munamal bark, black pepper, cloves, Pila roots, Katukarandu, cinnamon, Aralu (Chebulic myrobalan) and liquorice.
The initiative reflects the Hettigoda Group of Companies’ longstanding commitment to traditional medicine, health education and community wellbeing. Its portfolio spans medicinal products, herbal healthcare and personal care products, food supplements, herbal teas and oral care products, alongside a hospital, resorts and treatment centres offering traditional treatments. The Group also supports healthcare and education initiatives and contributes to preserving Sri Lanka’s traditional medicinal heritage.
“As the first herbal toothpaste in Sri Lanka and the first to undergo a clinical trial specifically investigating its effects on gingivitis, Siddhalepa Supirivicky represents an important milestone in our commitment to bringing indigenous Ayurvedic knowledge into everyday oral care. Our collaboration with the University of Würzburg, Germany, reflects our commitment to examining the role of our toothpaste through scientific research. We believe this work is an important step in strengthening the evidence behind our products and supporting the maintenance of healthy gums,” said Asoka Hettigoda, Chairman and Managing Director of the Hettigoda Group.
Through Siddhalepa Supirivicky, the Hettigoda Group continues to bring together indigenous Ayurvedic knowledge and clinical research, with the published findings contributing to the scientific understanding of the toothpaste’s role in helping manage gingivitis as part of daily oral care.
